Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8
5 clinical trials · Condition
◉ Watch Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers (NCT04460937) | National Cancer Institute (NCI) | 2021-04-09 |
| Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes (NCT04501913) | City of Hope Medical Center | 2019-12-24 |
| Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes (NCT04183218) | Mayo Clinic | 2019-09-23 |
| Nutritional Supplementation in Reducing Complications in Patients With Locally Advanced Esophageal Cancer Undergoing Chemotherapy, Radiation Therapy, and/or Surgery (NCT04029857) | M.D. Anderson Cancer Center | 2019-03-14 |
Track Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.